Purchase Order W81K0221P0160
Award Date
10/1/21
Potential Completion Date
9/30/24
Potential Value
$690K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Biomerieux Inc.
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Eno Valley, NC 27712, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of the Army Medical Command awarded a $239,903 firm-fixed price purchase order to Biomerieux Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic solutions. The contract is for the provision of the BACT/ALERT FA PLUS (100 per) microbiology testing system and associated reagents. This requirement was initially a sources sought notice to determine the availability of qualified sources for an automated blood culture monitoring and sepsis detection system to support...
This is a firm fixed price purchase order contract awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a foreign-owned for-profit manufacturer of clinical diagnostic products. The contract is to provide Biomerieux reagents and supplies to be used with government-owned analyzers, as well as the lease of a Virtuo B-Unit module, for the period of October 1, 2022 to September 30, 2023. The potential value of the contract is $249,612.61. This procurement was a sole source award under FAR...
The U.S. Defense Health Agency awarded a $164,800 firm fixed price purchase order to Biomerieux Inc., a foreign-owned, for-profit manufacturer of goods, to provide 200 boxes of blood culture bottles in various configurations (Bact/Alert FA Plus Aerobic, FN Plus Anaerobic, and PF Plus Pediatric). This sole source award was made without a set-aside under the authority of FAR 13.106-1(b)(1)(i) based on Biomerieux being the original equipment manufacturer of the BactAlert 3D Blood Culture Machine...
This firm-fixed-price contract was awarded to Biomerieux Inc. through its Biomerieux, Inc. division by the Defense Health Agency, an agency within the U.S. Department of Defense. The contract, valued at $149,062.20, is for the procurement of a new automated blood culture analyzer system to be installed at the Martin Army Community Hospital in Fort Moore, Georgia. The original solicitation was a sole-source special notice, with no set-aside designation. Biomerieux Inc. is a global leader in in...
The U.S. Defense Health Agency awarded a $103,972.90 firm-fixed-price contract to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of microbiology analyzers and reagents to support the Keesler Medical Center. The contract, which runs from October 1, 2023, to March 31, 2025, with two six-month option periods, covers microbial identification testing, antimicrobial susceptibility testing, and blood culture testing, along with the necessary equipment, consumables, and...
The Department of the Army Medical Command awarded a firm fixed price definitive contract to Biomerieux Inc., a foreign-owned for-profit manufacturer, to provide a blood culture system and related supplies. The contract has a potential value of $198,337.60 and a completion date of August 14, 2022. The original solicitation was for a blood culture detection system. Biomerieux Inc. is a worldwide leader in in vitro diagnostics and has provided a range of clinical diagnostic testing products,...
The Defense Health Agency (DHA) awarded a firm-fixed price purchase order to Biomerieux Inc., a foreign-owned, for-profit manufacturer of goods, for the provision of reagents and kits for the Vitek-2 microbiology analyzer. The contract has a potential value of $155,415.20 and a completion date of September 18, 2023. This sole-source award was made without a set-aside under the authority of FAR 13.106-1(b) due to Biomerieux being the sole manufacturer and distributor of the required products....
The Department of the Army Medical Command awarded a firm-fixed-price purchase order contract to Biomerieux Inc., a foreign-owned for-profit manufacturer, to provide Procalcitonin (PCT) Category 30450-01 supplies for the Tripler Army Medical Center (TAMC) in Hawaii. The contract has a potential value of $120,449.61 and a period of performance from October 1, 2019 through September 30, 2022. This requirement was sole-sourced to Biomerieux under NAICS code 325413. Biomerieux holds several active...
This is a firm-fixed-price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Biomerieux Inc., a global leader in in vitro diagnostics. The contract, valued at $16,879.50, is for the provision of Biomerieux's proprietary diagnostic platforms, reagents, and test kits to support the agency's infectious disease testing and pathogen detection requirements. The contract does not have a set-aside designation, as Biomerieux is often the sole source provider for its specialized...
This firm-fixed-price contract, valued at $666,080.98, was awarded by the Defense Health Agency to Biomerieux Inc. through its Biomerieux, Inc. division. The contract is for the provision of MALDI-TOF mass spectrometers and bacterial identification/antibiotic susceptibility testing (ID/AST) analyzers, along with associated consumables, reagents, training, and maintenance support for the Dwight D. Eisenhower Army Medical Center. Biomerieux is a global leader in in vitro diagnostics and a frequent...